Keyphrases
1-year Follow-up
22%
Acute Heart Failure
100%
Adverse Outcomes
11%
All-cause Mortality
11%
Area under the Curve
11%
Blood Samples
11%
Central Laboratory
11%
Creatinine
100%
CTnI
100%
Favorable Risk
11%
Galectin-3 (Gal-3)
100%
Growth Differentiation factor-15 (GDF-15)
100%
Hazard Ratio
11%
Heart Failure
11%
Heart Failure Hospitalization
11%
Heart Failure Risk
11%
Index Admission
11%
Joint Modeling
11%
Model Combining
11%
Multimarker
11%
Multimarker Approach
11%
Multivariable
11%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
100%
Netherlands
11%
Pathophysiological Pathways
11%
Patient Management
11%
Patients with Heart Failure
11%
Prognostic Value
11%
Repeated Measurements
11%
Risk Discrimination
11%
Single Marker Analysis
100%
Soluble Suppression of Tumorigenicity 2 (sST2)
100%
Troponin
22%
INIS
adjustments
11%
biological markers
22%
blood
11%
creatinine
100%
curves
11%
growth
100%
hazards
11%
heart failure
100%
hospitals
11%
laboratories
11%
levels
11%
management
11%
modeling
11%
mortality
11%
netherlands
11%
patients
33%
peptides
100%
risks
33%
sampling
11%
suppression
100%
values
11%
women
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
100%
Adverse Outcome
11%
All Cause Mortality
11%
Biological Marker
22%
Brain Natriuretic Peptide
100%
Carcinogenicity
100%
Congestive Heart Failure
44%
Creatinine
100%
Galectin 3
11%
Growth Differentiation Factor 15
100%
Hexachlorophene
11%
Troponin I
22%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
11%
Blood Sampling
11%
Brain Natriuretic Peptide
100%
Creatinine
100%
Galectin-3
11%
Growth Differentiation Factor
100%
N-Terminus
100%
Troponin I
22%